The government also approved the use of a vaccine developed by AstraZeneca and Oxford University which will be the lead vaccine in India's immunisation programme until other shots are approved. "COVAXIN has generated excellent safety data with robust immune responses to multiple viral proteins that persist." China also did not publish detailed efficacy data for a vaccine it authorised on Thursday but its developer has shared interim data. "On what basis was this approval given when Bharat Biotech has NOT shown enough data proving safety & efficacy?" Gokhale has filed a request under India's right-to-information law asking the government for safety and other data for the two vaccines approved on Sunday.

Source: bd News24 January 03, 2021 11:48 UTC